Interleukin-1α as a Potential Prognostic Biomarker in Pancreatic Cancer.
Leonardo GiganteGwladys Gaudillière-Le DainAurélie BertautCaroline TruntzerFrançois GhiringhelliPublished in: Biomedicines (2024)
is an independent prognostic marker and could be considered a potential therapeutic target in pancreatic cancer patients.